Orexigen Therapeutics, Inc. (NASDAQ:OREX) Quarterly Basic Net EPS At 2016-03-31

0

For the year ended 2016-03-31 Orexigen Therapeutics, Inc. (NASDAQ:OREX) basic consolidated EPS came $-0.5238. Conversely, for the quarter ended 2016-03-31, it was $-0.5238.

EPS can be simply called as a fraction of profits that is disbursed against each outstanding share. It is measured using the formula – net profit/outstanding shares. The element ‘Per-share earnings’ is majorly utilized by market experts to give earnings and price projections. Suppose a group “S” announces a net profit of $15,000 in a given year. The count of outstanding shares is 300. So, its EPS will be $50. EPS is issued every quarter, indicating the stakeholders can evaluate the financial performance periodically.

EPS alone cannot indicate on the financial well-being of a firm. For a clear picture, it is vital to look into the price to earnings ratio of company.

EPS from continuing operations

Orexigen Therapeutics, Inc. (NASDAQ:OREX) EPS from continuing operations was $-0.5238 for the fiscal ended 2016-03-31. For the quarter ended 2016-03-31, this figure was $-0.5238.

EPS contribution from parent

Orexigen Therapeutics, Inc. (NASDAQ:OREX) confirmed basic EPS of $-0.5238 for the year ended 2016-03-31 from its parent group. Conversely, for the quarter closed 2016-03-31 it was $-0.5238.

Basic net EPS

Orexigen Therapeutics, Inc. (NASDAQ:OREX) basic net EPS was $-0.15 for the year ended 2016-03-31. For the quarter ended 2016-03-31, it came at $-0.15.

Consolidated diluted EPS

Orexigen Therapeutics, Inc. (NASDAQ:OREX) consolidated diluted EPS was -0.5238 for the year ended 2016-03-31. For the quarter ended 2016-03-31, it stood at $-0.5238.

Basic diluted EPS

Orexigen Therapeutics, Inc. (NASDAQ:OREX) basic diluted EPS was $-0.1535 for the quarter ended 2016-03-31. For the year ended 2016-03-31, basic diluted EPS was $-0.1535.

Net diluted EPS

Orexigen Therapeutics, Inc. (NASDAQ:OREX) posted net diluted EPS of $-0.52 for the fiscal closed 2016-03-31. For the quarter ended 2016-03-31, net diluted EPS was $-0.52.

Diluted EPS from parent

Orexigen Therapeutics, Inc. (NASDAQ:OREX) diluted EPS from parent group was $-0.5238 for the year ended 2016-03-31. For the quarter ended 2016-03-31 it stood at $-0.5238.

Orexigen Therapeutics, Inc. (NASDAQ:OREX) net basic EPS was $-0.52 for the year ended 2016-03-31. For the quarter ended 2016-03-31, it was $-0.52.

For the year ended 2016-03-31, basic shares outstanding were 131.129 while for the quarter ended 2016-03-31 is 131.129.

For the fiscal ended 2016-03-31, the diluted outstanding shares were 131.129 and for the quarter ended 2016-03-31 it was 131.129.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 6 times, 1 visits today)